Cervical mucus anti-sperm antibodies: Treatment with intrauterine insemination

William H. Kutteh, William Byrd, Linda Blankenship, Carol C. Kutteh, Bruce R. Carr

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

PROBLEM: To determine (1) the incidence of cervical mucus anti-sperm antibodies in infertile women, and (2) the results of treatment by intrauterine insemination. METHOD: Cervical mucus was collected the morning after urinary LH surge occurred from 153 consecutive women being treated for unexplained infertility with intrauterine insemination. Immunobead testing for IgG, IgA, IgA1, and IgA2 was performed with only actively motile sperm being counted. RESULTS: Overall, 23/153 (15.0%) of cervical mucus samples were positive for anti-sperm antibodies: 9/23 (39.1%) were only IgA-positive (62% IgA1-positive, 38% IgA2-positive), 11/23 (47.8%) were only IgG-positive, and 3/23 (13.0%) were positive for both IgA and IgG. Insemination resulted in a pregnancy in 6/23 (26.1%) of women with cervical mucus anti-sperm antibodies after 1-3 cycles. CONCLUSIONS: Testing for cervical mucus anti-sperm antibodies should be performed in cases of 'unexplained' infertility, and intrauterine insemination may be an effective treatment, resulting in pregnancies in over one-fourth of couples.

Original languageEnglish (US)
Pages (from-to)429-433
Number of pages5
JournalAmerican Journal of Reproductive Immunology
Volume35
Issue number4
StatePublished - Apr 1996

Fingerprint

Cervix Mucus
Insemination
Immunoglobulin A
Spermatozoa
Anti-Idiotypic Antibodies
Immunoglobulin G
Infertility
Therapeutics
Pregnancy
Incidence

Keywords

  • Anti-sperm antibodies
  • Cervical mucus
  • Immunoglobulin a
  • Intrauterine insemination

ASJC Scopus subject areas

  • Immunology
  • Obstetrics and Gynecology

Cite this

Cervical mucus anti-sperm antibodies : Treatment with intrauterine insemination. / Kutteh, William H.; Byrd, William; Blankenship, Linda; Kutteh, Carol C.; Carr, Bruce R.

In: American Journal of Reproductive Immunology, Vol. 35, No. 4, 04.1996, p. 429-433.

Research output: Contribution to journalArticle

Kutteh, WH, Byrd, W, Blankenship, L, Kutteh, CC & Carr, BR 1996, 'Cervical mucus anti-sperm antibodies: Treatment with intrauterine insemination', American Journal of Reproductive Immunology, vol. 35, no. 4, pp. 429-433.
Kutteh, William H. ; Byrd, William ; Blankenship, Linda ; Kutteh, Carol C. ; Carr, Bruce R. / Cervical mucus anti-sperm antibodies : Treatment with intrauterine insemination. In: American Journal of Reproductive Immunology. 1996 ; Vol. 35, No. 4. pp. 429-433.
@article{c63257b5b9464c4b8eda301901d4a5b6,
title = "Cervical mucus anti-sperm antibodies: Treatment with intrauterine insemination",
abstract = "PROBLEM: To determine (1) the incidence of cervical mucus anti-sperm antibodies in infertile women, and (2) the results of treatment by intrauterine insemination. METHOD: Cervical mucus was collected the morning after urinary LH surge occurred from 153 consecutive women being treated for unexplained infertility with intrauterine insemination. Immunobead testing for IgG, IgA, IgA1, and IgA2 was performed with only actively motile sperm being counted. RESULTS: Overall, 23/153 (15.0{\%}) of cervical mucus samples were positive for anti-sperm antibodies: 9/23 (39.1{\%}) were only IgA-positive (62{\%} IgA1-positive, 38{\%} IgA2-positive), 11/23 (47.8{\%}) were only IgG-positive, and 3/23 (13.0{\%}) were positive for both IgA and IgG. Insemination resulted in a pregnancy in 6/23 (26.1{\%}) of women with cervical mucus anti-sperm antibodies after 1-3 cycles. CONCLUSIONS: Testing for cervical mucus anti-sperm antibodies should be performed in cases of 'unexplained' infertility, and intrauterine insemination may be an effective treatment, resulting in pregnancies in over one-fourth of couples.",
keywords = "Anti-sperm antibodies, Cervical mucus, Immunoglobulin a, Intrauterine insemination",
author = "Kutteh, {William H.} and William Byrd and Linda Blankenship and Kutteh, {Carol C.} and Carr, {Bruce R.}",
year = "1996",
month = "4",
language = "English (US)",
volume = "35",
pages = "429--433",
journal = "American Journal of Reproductive Immunology",
issn = "8755-8920",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Cervical mucus anti-sperm antibodies

T2 - Treatment with intrauterine insemination

AU - Kutteh, William H.

AU - Byrd, William

AU - Blankenship, Linda

AU - Kutteh, Carol C.

AU - Carr, Bruce R.

PY - 1996/4

Y1 - 1996/4

N2 - PROBLEM: To determine (1) the incidence of cervical mucus anti-sperm antibodies in infertile women, and (2) the results of treatment by intrauterine insemination. METHOD: Cervical mucus was collected the morning after urinary LH surge occurred from 153 consecutive women being treated for unexplained infertility with intrauterine insemination. Immunobead testing for IgG, IgA, IgA1, and IgA2 was performed with only actively motile sperm being counted. RESULTS: Overall, 23/153 (15.0%) of cervical mucus samples were positive for anti-sperm antibodies: 9/23 (39.1%) were only IgA-positive (62% IgA1-positive, 38% IgA2-positive), 11/23 (47.8%) were only IgG-positive, and 3/23 (13.0%) were positive for both IgA and IgG. Insemination resulted in a pregnancy in 6/23 (26.1%) of women with cervical mucus anti-sperm antibodies after 1-3 cycles. CONCLUSIONS: Testing for cervical mucus anti-sperm antibodies should be performed in cases of 'unexplained' infertility, and intrauterine insemination may be an effective treatment, resulting in pregnancies in over one-fourth of couples.

AB - PROBLEM: To determine (1) the incidence of cervical mucus anti-sperm antibodies in infertile women, and (2) the results of treatment by intrauterine insemination. METHOD: Cervical mucus was collected the morning after urinary LH surge occurred from 153 consecutive women being treated for unexplained infertility with intrauterine insemination. Immunobead testing for IgG, IgA, IgA1, and IgA2 was performed with only actively motile sperm being counted. RESULTS: Overall, 23/153 (15.0%) of cervical mucus samples were positive for anti-sperm antibodies: 9/23 (39.1%) were only IgA-positive (62% IgA1-positive, 38% IgA2-positive), 11/23 (47.8%) were only IgG-positive, and 3/23 (13.0%) were positive for both IgA and IgG. Insemination resulted in a pregnancy in 6/23 (26.1%) of women with cervical mucus anti-sperm antibodies after 1-3 cycles. CONCLUSIONS: Testing for cervical mucus anti-sperm antibodies should be performed in cases of 'unexplained' infertility, and intrauterine insemination may be an effective treatment, resulting in pregnancies in over one-fourth of couples.

KW - Anti-sperm antibodies

KW - Cervical mucus

KW - Immunoglobulin a

KW - Intrauterine insemination

UR - http://www.scopus.com/inward/record.url?scp=0029985252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029985252&partnerID=8YFLogxK

M3 - Article

C2 - 8739465

AN - SCOPUS:0029985252

VL - 35

SP - 429

EP - 433

JO - American Journal of Reproductive Immunology

JF - American Journal of Reproductive Immunology

SN - 8755-8920

IS - 4

ER -